Intended Use:
This product is used for qualitative detection of neutralizing antibodies to 2019-nCoV in clinical samples (serum/plasma/ whole blood).
Principle:
The test kit contains fluorescently-labeled 2019-nCoV Spike Protein (RBD), ACE2 Protein immobilized in test area (T) and the corresponding antibody in quality control area (C).
Operation Steps
|
Result Interpretation
Reference Range: Inhibition rate≥20%
- Positive : Inhibition rate≥20%, the sample contains 2019-nCoV neutralizing antibodies.
- Negative : Inhibition rate<20%, the sample does not contain the 2019-nCoV neutralizing antibodies or its content is below the limit of detection.
- Invalid : No fluorescent signal is detected.